(Reuters) - Evolus, an anti-wrinkle injection maker, reported its first-ever quarterly profit on an adjusted basis on Wednesday, driven by strong sales of its Botox rival Jeuveau. The company, which ...

Botox has become so synonymous with anti-aging wrinkle treatments that many people use the name the same way they refer to tissues as Kleenex. But the brand power has a downside: Competitors have ...

The Neck Correct Cream is a neck and chest treatment with five main targets; horizontal tech-neck lines, wrinkles, firmness, ...

Botox manufacturer Allergan can move forward with its lawsuit against Nashville-based competitor Revance Therapeutics, alleging that Revance took company trade secrets. On Jan. 4, U.S. District Judge ...

NEW YORK (AP) — Botox maker Allergan Plc. is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as ...

Meet the new Botox: The one that’s injected 30 times directly into your bladder. As Irvine, Calif., Botox-maker Allergan slashes jobs, in part over slumping cosmetic sales of the beneficial toxin, it ...

NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to ...

(Reuters) - Botox-maker Allergan Plc, which is in talks to be bought by Pfizer Inc, reported a better-than-expected quarterly profit on strong sales of high-margin branded drugs, its biggest business.

AbbVie is buying Botox maker Allergan in a cash-and-stock deal valued at about $63 billion. The maker of the blockbuster immune disorder treatment Humira said Tuesday that it will pay $120.30 in cash ...

(Reuters) - Allergan Plc on Tuesday forecast 2019 revenue below expectations on looming competition for some of its top drugs, and shelved plans to sell its women's health business. The Botox maker's ...